Fennec Pharmaceuticals (FENC) Interest Expenses (2014 - 2025)

Fennec Pharmaceuticals' Interest Expenses history runs 10 years deep, the most recent figure standing at $2.4 million for Q4 2025.

• Quarterly Interest Expenses rose 147.2% year-over-year to $2.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.2 million (up 2.24% YoY) and the FY2025 annual result came in at $46.5 million, down 11.17% from the prior year.
• Interest Expenses was $2.4 million for Q4 2025 at Fennec Pharmaceuticals, up from $586000.0 in the prior quarter.
• Across five years, Interest Expenses topped out at $2.4 million in Q4 2025 and bottomed at $4000.0 in Q1 2021.
• A 5-year average of $641650.0 and a median of $669000.0 in 2022 frame the typical range for Interest Expenses.
• Annual changes were most pronounced in 2021 — Interest Expenses sank 99.8% — and 2022, when it jumped 1350.0%.
• Fennec Pharmaceuticals' Interest Expenses stood at $62000.0 in 2021, then surged by 1100.0% to $744000.0 in 2022, then grew by 22.98% to $915000.0 in 2023, then climbed by 5.57% to $966000.0 in 2024, then surged by 147.2% to $2.4 million in 2025.
• Business Quant data shows FENC's Interest Expenses at $2.4 million in Q4 2025, $586000.0 in Q3 2025, and $594000.0 in Q2 2025.